Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines

Journal of Pharmaceutical Sciences

Volumn 93, Issue 7, 2004, Pages 1924-1939

  Evans, Robert K ^a   Zhu, De Min ^a   Casimiro, Danilo R ^a   Nawrocki, Denise K ^a   Mach, Henryk ^a   Troutman, Robert D ^a   Tang, Aimin ^a   Wu, Shilu ^a   Chin, Stephen ^a   Ahn, Colette ^a   Isopi, Lynne A ^a   Williams, Donna M ^a   Xu, Zheng ^a   Shiver, John W ^a   Volkin, David B ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

DNA; DNA delivery; Immunology; Light scattering; Microparticles; Particle sizing; Vaccine adjuvants

Indexed keywords

BENZALKONIUM CHLORIDE; CATIONIC SURFACTANT; DNA VACCINE; GAG PROTEIN; PHOSPHATE; PLASMID DNA;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG FORMULATION; ELECTRICITY; EVALUATION; FLUORESCENCE MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; PHASE TRANSITION; PHYSICAL CHEMISTRY; POLYMERIZATION; RHESUS MONKEY; SURFACE CHARGE; TEMPERATURE MEASUREMENT;

EID: 3042588983     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20112     Document Type: Article

References (28)

1. Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, Lekutis C, Alroy M, Freed DC, Lord CI, Handt LK, Liu M, Shiver JW. 1997. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 94:9378-9383.
2. Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrom E, Wahren B. 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351:1320-1325.
3. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TP, Hobart M, Margalith M, Ng J, Weiss WR, Sedegah M, Taisne CD, Norman JA, Hoffman SL. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476-480.
4. MacGregor RR, Boyer J, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weine DB. 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host responses. J Infect Dis 178:92-100.
5. Newman MJ, Actor JK, Balusubramanian M, Jagannath C. 1998. Use of nonionic block copolymers in vaccines and therapeutics. Crit Rev Ther Drug Carrier Syst 15:89-142.
6. Hunter RL, Bennett B. 1984. The adjuvant activity of nonionic block copolymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. J Immnol 133:3167-3175.
7. Hunter RL, McNicholl J, Lal AA. 1994. Mechanisms of action of nonionic block copolymer adjuvants. Aids Res Hum Retroviruses 10(Suppl 2): S95-S98.
8. Casimiro DR, Chen L, Fu T-M, Evans RK, Caulfield MJ, Davies M-E, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu D-M, Nawrocki D, Mach H, Troutman R, Isopi L, Williams D, Hurni W, Xu Z, Smith JG, Wang S, Liu X, Guan L, Long R, Trigona W, Heidecker GJ, Perry HC, Persaud N, Toner TJ, Su Q, Liang X, Youil R, Chastain M, Bett AJ, Volkin DB, Emini EA, Shiver JW. 2003. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccina virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 77:6305-6313.
9. Shiver JW, Fu M, Chen L, Casimiro DR, Davies M, Evans RK, Zhang Z, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335.
10. Korber B, Kuiken C, Foley B, Hahn B, McCutchan F, Mellors J, Sodroski J. 1998. Human retroviruses and AIDS. Los Alamos, NM: Los Alamos National Laboratory.
11. Lathe R. 1985. Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. J Mol Biol 183:1-12.
12. Caulfield MJ, Wang S, Smith JG, Tobery TW, Liu X, Davies M-E, Casimiro DR, Fu T-M, Simon A, Evans RK, Emini EA, Shiver J. 2002. Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines. J Virol 76:10038-10043.
13. Shiver JW, Perry HC, Davies M-E, Liu MA. 1995. Immune responses to HIV gp120 elicited by DNA vaccination. In: Chanock RM, Brown F, Ginsberg HS, Norrby E, editors. Vaccines 95. Plainview, NY: Cold Spring Harbor Laboratory, p 95.
14. Mach H, Sanyal G, Volkin DB, Middaugh CR. 1997. Applications of ultraviolet absorption spectroscopy to the analysis of biopharmaceuticals, ASC Symposium Series No. 675. In: Shahrokh Z, Sluzky V, Cleland JL, Shire SJ, Randolph TW, editors. Therapeutic protein and peptide formulation and delivery. Washington, DC: American Chemical Society.
15. Musunuri S, Satishchandran C. 1999. Compositions and methods for delivery of genetic material. PCT Int Appl WO 99/21591.
16. Singh M, Briones M, Ott G, O'Hagan D. 2000. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97:811-816.
17. Ott G, Singh M, Kazzaz J, Briones M, Soenawan E, Ugozzoli M, O'Hagan DT. 2002. A cationic submicron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J Control Release 79:1-5.
18. Vemuri NM. 1994. Benzalkonium chloride. In: Wade A, Weller PJ, editors. Handbook of pharmaceutical excipients. London: The Pharmaceutical Press, pp 27-29.
19. Ulmer JB, DeWitt CM, Chastain M, Friedman A, Donnelly JJ, McClements WL, Caulfield MJ, Bohannon KE, Volkin DB, Evans RK. 2000. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 18:18-28.
20. Wang S, Liu X, Fisher K, Smith JG, Chen F, Tobery TW, Ulmer JB, Evans RK, Caulfield MJ. 2000. Enhanced type 1 immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate. Vaccine 18:1227-1235.
21. Casimiro DR, Tang A, Chen L, Fu T-M, Evans RK, Davies M-E, Freed DC, Hurni W, Aste-Amezaga JM, Guan L, Long R, Huang L, Harris V, Nawrocki DK, Mach H, Troutman RD, Isopi LA, Murthy KK, Rice K, Wilson KA, Volkin DB, Emini EA, Shiver JW. 2003. Vaccine-induced immunity in baboons using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 77:7663-7668.
22. O'Hagan D, Singh M, Ugozzoli M, Wild C, Barnett S, Minchao C, Schaefer M, Doe B, Otten GR, Ulmer JB. 2001. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J Virol 75:9037-9043.
23. Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B, O'Hagan D, Ulmer JB, Donnelly JJ, McDonald DM, Ott G. 2000. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 7:2105-2112.
24. Prokop A, Kozlov E, Moore W, Davidson JM. 2002. Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles. J Pharm Sci 91:67-76.
25. Inactive Ingredient Search for Approved Drug Products. 2004. FDA, CDER. http://www.accessdata. fda.gov/scripts/cder/iig/getiigWEB.cfm
26. Triozzi PL, Stevens VC, Aldrich W, Powell J, Todd CW, Newman MJ. 1997. Effects of a β-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin Cancer Res 3:2355-2362.
27. Evans RK, Xu Z, Bohannon KE, Wang B, Bruner MW, Volkin DB. 2000. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J Pharm Sci 89:76-87.
28. Gallet G, Carroccio S, Rizzarelli P, Karlsson S. 2002. Thermal degradation of poly(ethylene oxide-propylene oxide-ethylene oxide) triblock copolymer: Comparative study by SEC/NMR, SEC/MALDITOF-MS and SPME/GC-MS. Polymer 43:1081-1094.